OraSure Technologies | OSUR - Selling And Administration Expenses


OraSure Technologies reported $13.21M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Agilent USD 476M 48M Dec/2025
AngioDynamics USD 36.57M 3.79M Sep/2025
Becton, Dickinson and Co. USD 1.39B 27M Dec/2025
Bio Techne USD 113.69M 2.52M Dec/2025
Bio-Rad Laboratories USD 221M 14.2M Dec/2025
Bruker USD 247.2M 4.7M Dec/2025
Cerus USD 19.33M 1.55M Dec/2024
Charles River Laboratories USD 196.14M 18.55M Dec/2025
Danaher USD 1.86B 166M Mar/2026
Dentsply International USD 383M 28M Dec/2025
Dexcom USD 349.7M 49.8M Mar/2026
Illumina USD 272M 11M Mar/2026
Integra LifeSciences USD 156.45M 12.6M Dec/2025
Intuitive Surgical USD 613.3M 73.8M Mar/2026
IQVIA Holdings USD 468M 46M Dec/2025
Mesa Laboratories USD 27.31M 380K Sep/2024
Mettler Toledo International USD 259.83M 11.43M Dec/2025
Myriad Genetics USD 122.3M 6.7M Dec/2025
OraSure Technologies USD 13.21M 3.29M Dec/2025
Quidel USD 194.4M 7.5M Dec/2025
Repligen USD 74.36M 703K Dec/2025
Revvity USD 251.73M 9.82M Dec/2025
STAAR Surgical USD 38.94M 20.44M Dec/2025
Thermo Fisher Scientific USD 1.8B 179M Mar/2026
Trinity Biotech USD 6.19M 2.18M Sep/2025
Waters USD 394M 153.99M Mar/2026